Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects.

George DT, Benkelfat C, Rawlings RR, Eckardt MJ, Phillips MJ, Nutt DJ, Wynne D, Murphy DL, Linnoila M.

Am J Psychiatry. 1997 Jan;154(1):81-7.

PMID:
8988963
2.

Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.

Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C.

Alcohol Clin Exp Res. 1997 Apr;21(2):220-6.

PMID:
9113256
3.

Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.

Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS.

Am J Psychiatry. 1996 Jan;153(1):83-92.

PMID:
8540598
4.

Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.

Schwartz PJ, Turner EH, Garcia-Borreguero D, Sedway J, Vetticad RG, Wehr TA, Murphy DL, Rosenthal NE.

Psychiatry Res. 1999 Apr 19;86(1):9-28.

PMID:
10359479
5.
6.

Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.

Kühn KU, Quednow BB, Bagli M, Meyer K, Feuchtl A, Westheide J, Frahnert C, Maier W, Rao ML.

Pharmacopsychiatry. 2002 Nov;35(6):226-30.

PMID:
12518270
7.

Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.

Broocks A, Briggs NC, Pigott TA, Hill JL, Canter SK, Tolliver TJ, Baldemore D, Murphy DL.

Psychopharmacology (Berl). 1997 Mar;130(2):91-103.

PMID:
9106905
8.

The criteria of Cloninger et al. and von Knorring et al. for subgrouping alcoholics: a comparison in a clinical population.

Lamparski DM, Roy A, Nutt DJ, Linnoila M.

Acta Psychiatr Scand. 1991 Dec;84(6):497-502.

PMID:
1792921
9.

Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.

Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS.

Arch Gen Psychiatry. 1994 Nov;51(11):898-911.

PMID:
7944878
10.
11.

The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.

Scheepers FE, Gespen de Wied CC, Kahn RS.

J Clin Psychopharmacol. 2001 Dec;21(6):575-82.

PMID:
11763004
12.

Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.

Hommer D, Andreasen P, Rio D, Williams W, Ruttimann U, Momenan R, Zametkin A, Rawlings R, Linnoila M.

J Neurosci. 1997 Apr 15;17(8):2796-806.

13.

Serotonergic sensitivity in borderline personality disorder: preliminary findings.

Hollander E, Stein DJ, DeCaria CM, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham JM.

Am J Psychiatry. 1994 Feb;151(2):277-80.

PMID:
8296905
14.

Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.

Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH.

Am J Psychiatry. 1994 Nov;151(11):1626-30.

PMID:
7943451
15.

Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.

Terao T, Yoshimura R, Ohmori O, Takano T, Takahashi N, Iwata N, Suzuki T, Abe K.

Biol Psychiatry. 1997 May 1;41(9):974-8.

PMID:
9110103
16.

Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism.

George DT, Nutt DJ, Rawlings RR, Phillips MJ, Eckardt MJ, Potter WZ, Linnoila M.

Biol Psychiatry. 1995 Jan 15;37(2):112-9.

PMID:
7718674
18.

Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder.

Broocks A, Bandelow B, George A, Jestrabeck C, Opitz M, Bartmann U, Gleiter CH, Meineke I, Roed IS, Rüther E, Hajak G.

Int Clin Psychopharmacol. 2000 May;15(3):153-61.

PMID:
10870873
19.

Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.

Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC.

Arch Gen Psychiatry. 1992 Nov;49(11):852-61.

PMID:
1444722
20.

Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism.

Roache JD, Wang Y, Ait-Daoud N, Johnson BA.

Alcohol Clin Exp Res. 2008 Aug;32(8):1502-12. doi: 10.1111/j.1530-0277.2008.00717.x. Epub 2008 Jun 28.

Supplemental Content

Support Center